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ABSTRACT 
Objective: The present study aim to evaluate antimicrobial and antidiarrheal activities of phenol acid-rich fractions of roots from Ximenia 
americana L., in animal models in order to confirm the ethnomedicinal use of Ximenia Americana L., roots.  
Methods: In vitro antibacterial (Minimum inhibitory concentration (MIC), Minimum bactericidal concentration (MBC) and time-kill studies) of 
phenol-rich fractions of roots from Ximenia americana L., was assessed using eight bacteria strains (Gram-negative). The anti-diarrheal activity was 
evaluated using castor using castor oil induced diarrhea whereas Anti-secretory activity was investigated using castor oil-induced enteropooling 
assay examined in animal models respectively.  
Results: All test bacteria were susceptible to the phenol-rich fractions. Time-kill results showed that after 5 h exposition there was no viable 
microorganism in the initial inoculum. Moreover, phenol acid-rich fractions of roots (100-200 and 300 mg/kg, p. o.) produced dose-dependent and 
significant (p<0.05-0.001) protection of rats against castor oil-induced diarrhea, and delayed gastric emptying. Phenol acid-rich fractions of roots, 
dose-dependently and significantly (p<0.05-0.001) delayed the onset of castor oil induced diarrhea, decreased the frequency of defecation, and 
reduced the severity of diarrhea in the rats. Phenol acid-rich fractions caused dose-related inhibition of castor-oil-induced enteropooling in rats.  
Conclusion: The data analysis indicates that the tested of phenol-rich fractions has significant effects when compared with the standard antibiotic. 
These results, therefore, justify the traditional use of Ximenia americana L. About antidiarrheal activity, the findings of this study indicate that 
phenol acid-rich fraction possesses antidiarrheal property in rats. These findings confirm the ethnomedicinal use of Ximenia americana L., roots 
valuable natural remedy for the treatment, management and/or control of diarrhea. 
Keywords: Ximenia americana L., Phenol acid-rich fractions, Roots, Antimicrobial and antidiarrheal capacities 




Traditional cures and plant-based remedies remain the main solution 
to health problems in many developing countries [1]. According [2], 
medicinal plants usefulness was estimated that over 80% of 
developing countries populations have resorted to traditional 
medicine. Plants have been used for medical treatments through much 
of human history, and such medicine is still widely practiced today. 
Plant parts such as leaves, seeds, bark, berries, sap, roots, or flowers 
are widely used for their medicinal property. Moreover, since the time 
immemorial, medicinal plants have played an invaluable role in the 
development of therapeutic agents. Currently, it is estimated that 
about 80% of people living in developing countries still rely on 
traditional medicine for their primary health care [3]. 
There are many medicinal plants that possess antidiarrheal activity 
with lesser side effects than the conventional drugs. Diarrheal 
disease is a leading cause of mortality and morbidity, especially in 
developing countries and is responsible for the death of millions of 
people each year. In developing countries, the majority of people 
almost exclusively use traditional medicines in treating all sorts of 
diseases, including diarrhea. WHO has encouraged studies for 
treatment and prevention of diarrheal diseases depending on 
traditional medical practices. This may reduce the mortality rate in 
developing countries due to diarrhea. Tannins, alkaloids, flavonoids, 
and terpenoids are the major constituents that are primarily 
responsible for the antidiarrheal activity of these medicinal herbs 
[4]. In Burkina Faso, a range of medicinal plants have been widely 
used for the management of diarrhea and related gastrointestinal 
disorders by traditional healers [5]. However, the safety and 
therapeutic potentials of some of these medicinal plants have not 
been validated yet. Among them, Ximenia americana L., is one of the 
popular medicinal plants being used in the traditional medicine. 
Ximenia americana (Olacaceae) which is also known, is a shrub-like a 
plant found in abundance in the West African region. It usually 
flowers in the second part of the dry season, producing cream–white 
to greenish yellow flowers. The fruits are green but turn golden-
yellow or red. The fruit when eaten is very refreshing and has an 
almond acid taste. 
Phytochemical screening of the leaves and stem bark revealed the 
presence of saponins, glycosides, flavonoids, tannins, phenolics, 
alkaloids, quinones and terpenoids types. In addition, the plant is 
potentially rich in fatty acids and glycerides and the seeds contain 
derivatives cyanide [5]. 
It is reported that the plant is used in traditional medicine for 
treatment of malaria, fever, leprotic ulcers and skin infections of mixed 
origin in Northern parts of Nigeria [6]. The roots are used for treating 
abdominal pains, dysentery, inflamed joints and mouth ulcers [7]. In 
the ethnobotanical claims, and particularly in Burkina Faso, this plant 
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and particularly the roots are used for treating abdominal pains, 
dysentery, diarrhea, as a poison antidote, and infectious diseases in 
children such as malaria, fever, pain, and also have antibacterial, anti-
inflammatory, analgesic and hepatoprotective properties [5]. 
However, there is no scientific report available in support of the 
antidiarrheal and antipyretic activities of phenol acid of Ximenia 
americana L., roots. In this fact, the aim of the present work was 
evaluated the antidiarrheal and antipyretic activities of phenol acid of 
Ximenia americana L., roots for to provide a scientific basis for the 
traditional use of this ethnomedicinal plant in Burkina Faso.  
MATERIALS AND METHODS 
Plants material 
The vegetable materials (Fresh roots) of Ximenia america L., 
(Olacaceae) were collected in August 2014 in Dedougou, 230 Km West 
of Ouagadougou, capital of Burkina Faso. The plants were botanically 
identified by Dr. Traoré Lassina from the plants Biology Department of 
the University of Koudougou. A voucher specimen (MR_12) was 
deposited at the Herbarium of the Laboratoire de Biologie et 
d’Ecologie Végétales, UFR/SVT of the University of Ouagadougou. 
Bacterial strains and antibiotic 
Microorganisms used in this study were isolated from clinical samples 
at Laboratory of the General Hospital of Ouagadougou in Burkina Faso. 
Commercially available antibiotic diffusion discs (Ciprofloxacin: 10 
μg/disc) were purchased from Alkom Laboratories LTD. Clinical 
isolates were: Shigella dysenteriae, Shigella boydii, Shigella flexneri, 
Salmonella thyphi, Klebsiella pneumonia, Klebsiella arogenes, 
Escherichia coli, and Proteus mirabilis. The following microorganisms 
were all identified by the use of their biochemical profiles as 
recommended by the manual “Bactériologie Medical” [8]. 
Chemicals 
Acetone, oil ether, dichloromethane were supplied by Fluka Chemie 
(Buchs, Switzerland) Mueller Hinton agar and broth, Mac Farland, 
saline solution (Nacl), dimethylsulfoxide (DMSO) were purchased 
from Shijiazhuang. Pharma. Group. Zhangnua (China). Metamezole 
sodium (Sigma), loperamide (Sigma) and castor oil (Sigma) were 
purchased from Sigma (St. Louis, USA).  
Animals handling 
Swiss NMRI mice (25–30 g) of both sexes were used for acute 
toxicity, and Wister albino rats (180–240 g) of both sexes were used 
for antidiarrhea and antipyretic activities. All animals were housed 
in cages under controlled conditions of 12 h light/and 12 h without 
light and 25 °C. They received pellets of food enriched with 20% 
protein and water ad libitum. They were deprived of food for 15 h 
(but with access to drinking water) and weighed before the 
experiments. In vivo studies were carried out in accordance with 
guidelines for the care of laboratory animals and ethical guidelines 
for the investigation of experimental pain in conscious animals [9]. 
Preparation of aqueous acetone extract for acute toxicity study  
The field-grown fresh samples (roots) were washed with tap water 
followed by distilled water to remove the adhering dust particles. 
After blotting, the samples were air dried in the shade. The dried 
plant materials (roots) were ground to fine powder and stored in 
clean airtight containers. A sample of 50 g of stem barks was placed 
in the soxhlet and run by using 80% aqueous acetone (500 ml) in 
1/10 ratio (w/v) for 24 h under mechanic agitation at room 
temperature. After filtration, all the extracts were dried in a vacuum 
rotary evaporator at 40 °C under reduced pressure. Extracts were 
weighed and stored at 4 °C for further analysis. 
Fractionation of phenol acid-rich fractions for antidiarrhea and 
antipyretic activities 
Fifty grams (50g) of powdered plant material was extracted with 
80% aqueous acetone (500 ml) in 1/10 ratio (w/v) for 24 h under 
mechanic agitation (SM 25 shaker, Edmund BÜHLER, Germany) at 
room temperature. After filtration, acetone was removed under 
reduced pressure in a rotary evaporator (BÜCHI, Rotavapor R-200, 
Switzerland) at approximately 40 °C. The aqueous extracts were 
subjected to sequential liquid-liquid extraction with oil either to 
remove chlorophyll and other low molecular weight compounds and 
dichloromethane. This fraction (dichloromethane fraction) was then 
collected and concentrated to dryness under reduced pressure to 
obtain phenol acids (dichloromethane fraction). The fraction was 
freeze-dried by Telstar Cryodos 50 freeze-dryer. The fraction 
residues were packed in waterproof plastic flasks and stored at 4 °C 
until use. For the tests, the lyophilized sample was dissolved with 
10% DMSO in water at the desired concentration [5]. 
In vitro antimicrobial profile of phenol acid-rich fractions 
Preparation of inocula 
The susceptibility tests were performed by the Mueller Hinton agar-
well diffusion method [10]. The bacterial strains grown on nutrient 
agar at 37 °C for 18 h were suspended in a saline solution (0.9%, w/v) 
NaCl and adjusted to a turbidity of 0.5 Mac Farland standard 
(108CFU/ml). To obtain the inocula, these suspensions were diluted 
100 times in Muller Hinton broth to give 106colony forming units 
(CFU)/ml [11]. 
Preparation of discs 
The stock solutions of phenol acid-rich fractions of roots from 
Ximenia americana L., was dissolved in 10% dimethylsulfoxide 
(DMSO) in water [12] at a final concentration of 100 μg/ml after a 
serial two-fold dilution. Each stock solution of phenol acid-rich 
fractions was sterilized by filtration through 0.22 μm sterilizing 
Millipore express filter. The sterile discs (6 mm) were impregnated 
with 10 μL of the sterile phenol acid-rich fractions. Negative controls 
were prepared using discs impregnated with 10% DMSO in water 
and commercially available antibiotic diffusion discs (Ciprofloxacin) 
from Alkom Laboratories LTD) were used as positive reference 
standards (10 μg/disc) for all bacterial strains. 
Disc-diffusion assay 
Petri plates (9 cm) were prepared with 20 ml of a base layer of 
molten Mueller Hinton agar (DIFCO, Becton Dickinson, USA). Each 
Petri plate was inoculated with 15 μl of each bacterial suspension 
(106
Discs containing Ciprofloxacin (10 μg/disc) were used as positive 
controls and 10% DMSO was used as a negative control. The plates 
were incubated for 24 h at 37 °C and at 44 °C for Escherichia coli 
because this bacterium is thermo-resistant. The diameters of the 
inhibition zones were evaluated in millimeters. The phenol acid-rich 
fractions inducing inhibition zone ≥ 3 mm around disc were 
considered as antibacterial. All tests were performed in triplicate, 
and the bacterial activity was expressed as the mean of inhibition 
diameters (mm) produced [13]. 
 CFU/ml). After drying in a sterile hood, 6 mm diameter discs 
soaked with 10 μl of the different phenol acid-rich fractions dilutions 
were placed on the agar. 
Micro-well dilution assay 
Minimum inhibitory concentration (MIC) was determined by the 
microdilution method in culture broth as recommended by [14]. 
Eight serial two-fold dilutions of phenol acid-rich fractions were 
prepared as described before, to obtain a final concentration range 
of 400 to 3.125μg/ml. The 96-well micro-plates (NUNC, Danemark) 
containing 100 μL of Mueller Hinton (MH) broth were used. For each 
bacteria strain, three columns of eight wells to the micro-plate were 
used. Each well has getting: the culture medium+phenol acid-rich 
fractions+inoculum (10 μl of inocula) and INT (50 μl; 0.2 mg/ml). 
The plates were covered and incubated at 37 °C and at 44 °C for 
Escherichia coli for 24 h. All tests were performed in triplicate and 
the bacterial activity was expressed as the mean of inhibitions 
produced. Inhibition of bacterial growth was judged by rose or 
yellow colour. The MIC was defined as the lowest concentration of 
extract or fraction of extract at which no colony was observed after 
incubation. So, the MIC was defined as the lowest concentration at 
which no visible growth was observed. 
Minimal bactericidal concentration (MBC)  
Minimum bactericidal concentration (MBC) was recorded as a 
lowest phenol acid-rich fractions concentration killing 99.9% of the 
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bacterial inocula after 24 h incubation at 37 °C. Each 
experiment was repeated at least three times. MBC values were 
determined by removing 100 μl of bacterial suspension from 
subculture demonstrating no visible growth and inoculating 
nutrient agar plates. Plates were incubated at 37 °C for a total 
period of 24 h.  
The MBC is determined with the wells whose the concentrations are 
≥ MIC [13, 15]. The MBC was determined in Mueller Hinton (MH) 
agar (DIFCO, Becton Dickinson, USA) medium. 
Evaluation of bactericidal and bacteriostatic capacity 
The action of an antibacterial on the bacterial strains can be 
characterized with two parameters such as Minimum inhibitory 
concentration (MIC) and Minimum bactericidal concentration 
(MBC). According to the ratio MBC/MIC, we appreciated 
antibacterial activity. If the ratio MBC/MIC = 1 or 2, the effect was 
considered as bactericidal but if the ratio MBC/MIC = 4 or 16, the 
effect was defined as bacteriostatic [16]. 
Time-kill assay  
A bactericidal effect is defined as a 3Log decrease in the CFU/ml 
or a 99.9% kill over a specified time [17]. The definition of kill 
for this study has been used as per [18]. Kill-time can be 
determined at 6h [19]. A 90% kill at 6 h is equivalent to a 99.9% 
kill at 24 h [20]. In this study, the kill measurement was 
determined by the actual reduction in viable counts at 6 h for 
each isolate. Bacteria strains possessing the bactericidal effect 
were chosen to perform the time-kill assay. Thus, 0.5 Mac 
Farland standards suspensions of the microorganisms were 
diluted to have 50 ml of approximately 106
The method described by [23] was used for studying the 
antipyretic effect of phenol-acid-rich fractions of roots from 
Ximenia americana L. Thirty rats of both sex weighing 180-240 
grams were divided into five groups of six rats in each. All rats 
were made hyperthermic by subcutaneous injection of brewer’s 
yeast in physiological saline in a dose of 1.5 g/kg b. wt. After 17 h, 
the initial body temperature of each rat was measured rectally 
using a medical thermometer. The first group was kept as control; 
the second group was given metamezole sodium 50 mg/kg b. wt. 
as a standard antipyretic. The third, fourth and five groups were 
used to reveal the antipyretic effect of the tested phenol-acid-rich 
fractions of roots from Ximenia americana L., when given orally in 
a dose of 200, 250 and 300 mg/kg body weights, respectively. The 
body temperature of each rat was then recorded every hour for 3 
successive hours. 
Antidiarrheal activity test 
Castor oil-induced diarrhea 
The method of Awouters was followed for carrying out the study 
[24]. Rats of both sexes were fasted (without food, but water) for 
18 h. The selected rats for castor oil-induced diarrheal test were 
divided into five groups (n=10). Animals in the positive control 
groups received loperamide (5 mg/kg) body weight, and the 
control group received 0.9% normal saline (2 ml/kg) orally while 
those in the test groups received phenol-rich acid fractions at the 
doses of 100, 200, and 300 mg/kg body weight. After 1 h, all 
groups received castor oil 1 ml each orally. Then they were placed 
in cages lined with adsorbent papers and observed for 4h for the 
presence of characteristic diarrheal droppings. 100% was 
considered as the total number of feces of the control group the 
activity was expressed as % inhibition of diarrhea. The percent 
(%) inhibition of defecation was measured.  
The percentage inhibition of defecation was:  
 CFU/ml in nutriment 
broth, and the concentration corresponding to the best MIC, 
were respectively added to the corresponding culture. The 
cultures were incubated at 37 °C. At 0, 1, 2, 3, 4, 5 and 6 h, an 
aliquot of 100 μl was removed and diluted with 10 ml sterile 
broth. The obtained suspension was used to inoculate 9 cm 
diameter Petri plates with a sterile, nontoxic cotton swab on a 
wooden applicator as indicated before in the agar-well diffusion 
assay. After 24 h incubation at 37 °C, the viability of the 
microorganisms was evaluated by the presence of colonies on 
the plates. The experiment was carried out twice following [21] 
method with light modifications. 
Biological activities  
Acute toxicity study in mice of aqueous acetone extract  
Healthy male and female Swiss mice (25-30g) were randomly 
divided into 7 groups (1 control group and 6 treated assay groups) 
of 6 animals (3 male and 3 female). The control group received 
water containing 10% dimethylsulfoxide (DMSO) administered 
intraperitoneally. The water/acetone of extract of roots from 
Ximenia americana L., suspended in 10% DMSO was administered 
respectively intra-peritoneally at doses of 1; 2; 2.5; 3; 4; 5 and 6g/kg. 
The general behavior of the mice was observed for 120 min after the 
treatment. The animals were observed for morbidity and mortality 
once a day for 14 d. The number of survivors after the 14 d periods 
was noted. The toxicological effect was assessed on the basis of 
mortality for 14 d, which was expressed as the median lethal dose 
(LD50) (Lethal Dose 50) was estimated from the regression of log-
probit mortality rate [22]. 
Antipyretic activity test 
 
Where 𝐴𝐴 is mthe ean number of defecation time caused by castor oil 
and 𝐵𝐵 is mean number of defecation time caused by drug or fraction. 
Castor oil-induced enteropooling assay 
Castor oil-induced enteropooling test helps to determine the 
prevention of fluid accumulation ability of fraction. The test animals 
were fasted (without food, but water) for 18h prior to the 
commencement of the experiment. They were divided into five 
groups (n=10). Animals in the positive control groups received 
loperamide (5 mg/kg) body weight, and the control group received 
0.9% normal saline (2 ml/kg) orally while those in the test groups 
received phenol acid-rich fractions at the doses of 100, 200, and 300 
mg/kg body weight. Immediately after these administrations, 1 ml of 
castor oil was administered orally to each rat in all the groups. After 
30 min, the rats were sacrificed. At half an hour, all rats were 
sacrificed, and the small intestine from (the pylorus to the caecum) 
was isolated. The intestinal contents were collected by milking into a 
graduated tube, and their volume was measured [25]. The inhibition 




The data were expressed as mean±Standard deviation (SD) of six 
determinations (n=6). Results were analyzed by one-way ANOVA 
followed by Dunnett t-test using Prism 4 software. The level of 
significance was accepted at p ≤0.05. 
RESULTS AND DISCUSSION 
Antimicrobial profiles 
In this present study, ten bacteria strain (Gram-negative and Gram-
positive bacteria) were used. The antibacterial assays were 
performed by the agar-well diffusion and the broth microdilution 
methods; so that they could be qualified and quantified by inhibition 
zone diameters, Minimum inhibitory concentration (MIC), Minimum 
bactericidal concentration (MBC) and Time-kill assays. One noticed 
that the susceptibility of the bacteria to the phenol acid-rich 
fractions on the basis of inhibition zone diameters varied according 
to the microorganism, the results are reported in (table 1). There is a 
significant variation in the diameters of inhibition zone values (DIZ) 
of phenol acid-rich fractions (table 1). 
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Table 1: Inhibition zone diameters (mm) recorder in agar well diffusion assay using phenol acid-rich fractions from Ximenia americana 
and Ciprofloxacin (10μg/disc) 
Microorganisms Ciprofloxacin (10μg) Phenol acid-rich fractions 
Proteus mirabilis 21.66±0.58 25.66±1.53 
Shigella dysenteria 22.00±1.00 29.66±0.58 
Shigella boydii 22.66±0.58 21.33±4.04 
Shigella flexneri nd 23.66±4.93 
Salmonella thyphi 23.66±0.58 29.00±1.00 
Klebsiella pneumonia 20.66±0.54 nd 
Klebsiella arogenes 19.66±0.58 16.00±1.00 
Escherichia coli 18.00±0.58 20.00±1.00 
The results are the means of a number of the colonies±standard deviations. 
 
nd: no detected activity 
As for the micro-well dilution assay (MIC) and Minimum bactericidal 
concentration (MBC) of phenol acid-rich fractions, result varied 
according to the microorganism (table 2). The MIC values were ranged 
from 25 to 100 μg/ml and for the MBC values were ranged from 50 to 
400 μg/ml. The bactericidal and bacteriostatic effect of phenol acid-
rich fractions was determined using the ratio MBC/MIC (table 2). 
 
Table 2: Bacteriostatic (-) and Bactericidal (+) effects of phenol acid-rich fractions of roots from Ximenia americana L 
Microorganisms MIC (µg/ml) MBC (µg/ml) Effects 
Proteus mirabilis 25±0.00 50±0.00 + 
Shigella dysenteria 50±00 100±0.00 + 
Shigella boydii 25±0.00 50±0.00 + 
Shigella flexneri 25±0.00 50±0.00 + 
Salmonella thyphi 25±0.00 50±0.00 + 
Klebsiella arogenes 100±0.00 400±0.00 - 
Escherichia coli 100±0.00 400±0.00 - 
The results are the means of a number of the colonies±standard deviations, +: bactericidal effect,-: bacteriostatic effect. 
 
Table 3: Viability of microorganisms after 6 h exposure of phenol acid-rich fractions of 
Microorganisms Time-kill (h) 
0h 1h 2h 3h 4h 5h 6h 
Proteus mirabilis +(UC) +(UC) +(UC) +(UC) 147 12 - 
Shigella dysenteria +(UC) +(UC) +(UC) +(UC) 102 10 - 
Shigella boydii +(UC) +(UC) +(UC) +(UC) 37 - - 
Shigella flexneri +(UC) +(UC) +(UC) +(UC) 08 - - 
Salmonella thyphi +(UC) +(UC) +(UC) +(UC) - - - 
Roots from Ximenia americana L, the results are the means of a number of the colonies±standard deviations, +: For the presence of the colonies, -: 
for the absence of colonies 
 
Concerning the time-kill assay of phenol acid-rich fractions (table 3), 
the results showed that after 5 h exposition there was no viable 
microorganism in the initial inoculums. The effect of phenol acid-
rich fractions was faster on Salmonella thyphi than the other bacteria 
strains (table 3). 
UC: uncountable 
Medicinal plants have long been utilized as a source of therapeutic 
agents worldwide [26]. Previous studies have been carried out in 
different parts of the globe to extract plant products for screening 
antibacterial activity [27]. Plants produce highly bioactive molecules 
that allow them to interact with other organisms in their 
environment. Many investigators have evaluated the bioactivity of 
plant extracts and the isolated constituents against the serious 
infectious organisms [28]. In Africa, for the treatment of several 
infections, indigenous medicinal plants are often the only means 
[29]. Infectious due to multidrug-resistant microorganisms, pose an 
important clinical problem. Many of the bacterial strains are 
resistant to the standard antibiotic (Ciprofloxacin etc.) 
comparatively to the phenol acid-rich fractions. One could say that 
the metabolites have been shown to be responsible for the 
therapeutic activity of plants [30]. According to a recent study, 
Ximenia americana L. contains saponins, glycosides, flavonoids, 
tannins, phenolics, alkaloids, quinones, and terpenoids types [5]. The 
natural products were found to possess promising antimicrobial, 
and the metabolites have been shown to be responsible for the 
therapeutic activity of plants [31].  
The data analysis indicates that the tested polyphenol extract 
showed the significant results when compared with the standard 
antibiotic. Indeed, the antibacterial activity profile of the isolated 
constituents (polyphenols) when compared with antibiotic effects 
shows that the activity depends on the pure form of the constituents. 
This may be due to the fact that the bioactive constituents such as 
polyphenol compounds were responsible for the antimicrobial 
activity. In effect, some previous studies showed that polyphenolic 
compounds cause inhibition of a wide range of microorganisms. 
Phenol is well known as a chemical antiseptic [32].  
In addition, Phenolic and terpenic antimicrobial activities are well 
documented [13]. Polyphenols, such as tannins and flavonoids, are 
important for antibacterial activity [29]. The antimicrobial activity of 
flavonoids is due to their ability to complex with extracellular and 
soluble protein and to complex with bacterial cell wall while that of 
tannins may be related to their ability to inactivate microbial 
adhesions, enzymes and cell envelop proteins [33]. Then, 
Polyphenols, such as tannins and flavonoids, are important 
antibacterial activity [34]. Also, polyphenols have a good 
antimicrobial activity against the biggest number of bacterial as such 
Escherichia coli, Proteus mirabilis, Salmonella typhimurium [35].  
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Our data noticed that certain bacteria are resistant to the standard 
antibiotic compared to the phenol acid-rich fractions. The resistance of 
these bacteria towards antibacterial substances is related to the 
hydrophilic surface of their outer membrane which is rich in 
lipopolysaccharide molecules, presenting a barrier to the penetration 
of numerous antibiotic molecules and is also associated with the 
enzymes in periplasme space, which are capable of breaking down the 
molecules introduced from outside [36]. The resistances of the 
bacteria to the current antibiotics necessitate the further studies on 
the isolated constituents to find out their safety and efficacy profile. 
This highlights the continuous interest in laboratory screening of 
medicinal plants, not only to determine the scientific rationale for their 
usage but also to discover new active principles. Briefly, our results 
indicate good in vitro antimicrobial activities. 
Acute toxicity study in mice 
The effect of intraperitoneal treatment of the aqueous acetone 
extract from Ximenia americana L., on mortality, LD50 
Antipyretic effects 
is 3270.8 
mg/Kg body weight for intraperitoneal administration. No 
significant difference in body weight gain of the treated assay groups 
over the period of observation. No statistical difference was 
observed between the organ weights in the control and the 
intraperitoneal route groups. At acute toxicity level, data indicated 
that extract of Ximenia americana L., can be considered as weakly 
poisonous. According to Diez [21], pharmacological substances 
whole LD50 with less than 5 mg/kg body weight are considered not 
toxics; those with a LD50 between 5 mg/kg body weight and 5000 
mg/kg body weight are classified in the range of moderately toxic 
substances and those with the lethal dose is more than 5000 mg/kg 
body weight are classified in the range of highly toxic substances. In 
this fact, if we refer to this classification, we could say that the 
extract of Ximenia americana L., is moderately toxic and would be 
regarded as being safe or of low toxicity [22]. This is an indication 
that the aqueous acetone extract of Ximenia americana L., has 
negligible level of toxicity when administered orally. 
The antipyretic effect of phenol-acid rich fractions of roots was studied 
in hyperthermic rats using brewer's yeast and data were recorded in 
(table 4). The subcutaneous injection of brewer's yeast suspension 
markedly elevated rectal temperature after 17 h of administration. 
Oral administration of phenol-acid rich fractions of roots induced 
significant antipyretic activity at a dose of 300 mg/kg b. wt., while the 
low dose 250 mg/kg failed to decrease the raised body temperature. 
The effect of the high dose of 300 mg/kg b. wt., nearly similar to that of 
the standard metamezole sodium (50 mg/kg b. wt.) after 3 h. 
Significance was indicated by lowering the body temperature were 
(36.66±0.14 and 36.85±0.11) after 2 h of administration of the 
standard drug and root fractions, respectively and at 3 h (36.62±0.1 
and 36.81±0.15) when compared to the control non-treated group. 
 
Table 4: Antipyretic effect of phenol acid-rich fractions of roots from Ximenia americana L., hyperthermic rats (mean±SE, N=6) 
Treatment Dose (mg/Kg b. wt.) Rectal temperature (°C) 
Before treatment 1 h 2 h 3 h 
Control 0 37.69±0.15 37.63±0.1b 37.57±0.14c 37.68±0.2c e 
Metamezole sodium (Standard) 50 37.50±0.11 36.55±0.12a 36.66±0.14a 36.62±0.10a 
phenol acid-rich fractions 
a 
200 37.76±0.1 37.72±0.11c 37.76±0.11d 37.62±0.11e 
250 
d 
37.79±0.11 37.76±0.1d 37.71±0.14e 37.54±0.1d 
300 
c 
37.83±0.2 37.10±0.2e 36.85±0.11b 36.81±0.15b b 
Values represent the mean±SE of five animals for each group, values in each column with different superscript letters (a, b, c, d, e) are significantly 
different at P<0.05. 
 
About antipyretic potential, one could say that antipyretic activity may 
be attributed to the presence of phytochemical constituents such as β-
sitosterol triterpenes, flavonoids, saponins, glycosides, tannins, and 
alkaloids [37]. The β-sitosterol reduces PG and leukotrienes synthesis 
and in turn shows anti-inflammatory and antipyretic activity by 
inhibiting the pro-inflammatory cytokines and TNF-α [38, 39].  
Antidiarrheal affects 
Castor oil-induced diarrheal model 
In case of castor-oil induced diarrheal model, phenol acid-rich 
fractions at the doses of 100, 200, and 300 mg/kg, exerted 
statistically significantly (p<0.001) decreased and dose-dependent 
inhibition of the total number of diarrheal feces compared with the 
control groups (table 5). 
Castor oil-induced enteropooling assay 
The administration of castor oil resulted in intestinal fluid 
volumes and weights of the intestinal contents of the rats (from 
the pylorus to the caecum) were statistically significantly 
(p<0.001) and dose-dependently reduced by both phenol acid-
rich fractions at the doses of 200, and 300 mg/kg compared to 
the control group (table 6). 
 
Table 5: The antidiarrheal effect of phenol acid-rich fractions of roots from Ximenia americana L., on castor oil-induced diarrhea models in rats 
Treatment Dose (mg/kg) Total number of feces % of inhibition Total number of diarrheal feces % of inhibition 
Control 2 ml/kg 20.17±0.54 - 14.12±0.11 - 




100 12.53±0.10* 37.87 7.89±0.37* 44.12 
200 10.21±0.37*** 49.38 5.80±0.11*** 58.92 
300 8.02±0.63*** 60.23 4.78±0.23*** 66.15 
Each value is presented as the mean±SEM (n=10), phenol acid-rich fractions of roots from Ximenia americana L., ***p<0.001 compared with the control 
group (Dunnett’s Test), **p<0.01 compared with the control group (Dunnett’s Test), *p<0.05 compared with the control group (Dunnett’s Test). 
 
Table 6: The Anti-secretory effect of phenol acid-rich fractions of roots from Ximeniaamericana L., on castor oil-induced enteropooling 
assay in rats 
Treatment Dose (mg/kg) Volume of intestinal content (mL) 
Control 2 ml/kg 2.18±0.11 
Loperamide 5 0.63±0.45** 
phenol acid-rich fractions 100 1.12±1.63 
200 0.96±0.53* 
300 0.78±0.10** 
Each value is presented as the mean±SEM (n=10), ***p<0.001 compared with the control group (Dunnett’s Test), **p<0.01 compared with the 
control group (Dunnett’s Test), *p<0.05 compared with the control group (Dunnett’s Test) 
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Phenol acid-rich fractions of roots were evaluated for its 
antidiarrheal potential against castor oil induced diarrhea model in 
rats. In respect to demonstrate the probable mechanisms, the anti-
secretory effect was also tested using castor oil induced 
enteropooling assay in rats. Loperamide, the standard drug, 
generally produces rapid and sustained inhibition of the peristaltic 
reflex through depression of longitudinal and circular muscle 
activity. It is well known to reduce the daily fecal volume and 
decreases intestinal fluid and electrolyte loss. The antidiarrheal 
activity of, phenol acid-rich fractions of roots was comparable to the 
standard drug, loperamide, which at present is one of the most 
efficacious and widely employed antidiarrheal drugs. In our 
investigation, loperamide proved the claims by causing effectively 
antagonizes diarrheal activity induced by castor oil. It also decreases 
the number of diarrheal feces. It is widely known that castor oil is 
metabolized into ricinoleic acid in the gut, reduce active Na+and 
K+absorption and decrease Na+/K+ATPase activity in the small 
intestine and colon. As with other laxatives, castor-oil changes the 
electrolyte permeability of the intestinal mucosal membrane [40]. In 
the castor-oil induced diarrhea model in rats, phenol acid-rich 
fractions of roots showed dose-dependent manner and significant 
(p<0.001) reduced in the number of feces and the number of 
diarrheal feces with the percentage of inhibition (table 5). In the 
castor oil-induced enteropooling assay, castor oil produces 
permeability changes in the intestinal mucosal membranes to water 
and electrolytes resulting in fluid and watery luminal content that 
flows rapidly through the small and large intestines. The Anti-
secretory effect of phenol acid-rich fractions of roots significantly 
(p<0.001) inhibited the castor oil-induced intestinal fluid 
accumulation. The intestinal content was, however, more viscous in 
extract treated than in control rats. 
CONCLUSION 
The present study thus proves that phenol acid-rich fractions of 
roots from Ximenia americana L., possesses on a one hand significant 
antimicrobial activities to treat infectious diseases due to multi-
resistant bacterial strains. On the other hand, the study also proves 
the anti-diarrheal activity of phenol acid-rich fractions of roots from 
Ximenia americana L., due to its inhibitory effect among castor oil 
induced diarrhea, and castor oil induced enteropooling assay. The 
study though supports the traditional claim; further studies are 
needed to identify the chemical constituents that are responsible for 
the antidiarrheal effect. In conclusion, it appears that the phenol 
acid-rich fractions of roots from Ximenia americana L., possesses 
antidiarrheal, anti-motility and anti-secretory activities and thus can 
be developed for use in the treatment of diarrhea. 
AUTHORS CONTRIBUTIONS 
All the author have contributed equally 
CONFLICT OF INTERESTS 
All the authors had equal contribution in the manuscript and 
declared no conflict of interests. 
REFERENCES 
1. Azaizeh H, S Fulder, K Khalil, O Said. Ethnomedicinal 
knowledge of local arab practition ersin the middle east region. 
Fitoterapia 2003;74:98-108. 
2. OMS; 2003. Available from: http://ww.int/mediactre/ factsheets/ 
fs134/fr/. [Last accessed on 25 Feb 2018]. 
3. Pathak K, Das RJ. Herbal medicine-a rational approach in health 
care system. Int J Ayurvedic Herbal Med 2013;1:86-9. 
4. Komal S, Kumar S, Rana A. Herbal approaches for diarrhea: a 
review. IRJP 2013;4:31–8. 
5. Nacoulma OG. Medicinal plants and their traditional uses in 
Burkina Faso. Ph. D. Thesis: University of Ouagadougou; 1996. p. 
328.  
6. Ogunleye DS, Ibitoye SF. Studies of antimicrobial activity and 
chemical constituents of Ximenia americana. Trop J Pharm Res 
2003;2:239-41. 
7. Ake AI, Guinko S. In: Plants used in traditional medicine in West 
Africa. F. Hoffman, La Roche Ltd. Basel Switzerland; 1991. p. 100. 
8. Le Minor L, Veron M. Bactériologie Médicale. Edited by: 
Flammarion medecine-sciences 773; 1984. 
9. M Zimmermann. Ethical guidelines for investigations of 
experimental pain in conscious animals. Pain 1983;16:109-10. 
10. Perez C, Pauli M, Bazerque P. An antibiotic assay by the agar-
well diffusion method. Acta Biol Med Experimentalis 
1990;15:113-5. 
11. Ezoubeiri A, Gadhi CA, Fdil N, Benharref A, Jana M, Vanhaelen 
M. Isolation and antimicrobial activity of two phenolic 
compounds from Pulicariaodora L. J Ethnopharmacol 
2005;99:287-92. 
12. Pujol V, Villard J. Research of antifungal substances secreted by 
higherfungi in culture. French Pharm J 1990;48:17-22. 
13. Rabe T, Mullholland D, van Staden J. Isolation and identification 
of antibacterial compounds from Vernonia colorata leaves. J 
Ethnopharmacol 2002a;80:91-4. 
14. NCCLS-National Committee for Clinical Laboratory Standards. 
Performance standard for antimicrobial susceptibility testing: 
eleventh informational supplement. Document M100-S11. 
National Committee for ClinicalLaboratory Standard, Wayne, 
PA, USA; 2001a. 
15. Traore R. Contribution has the study of the adhesion of 
enterobacteries of the kinds Klebsiella proteus and K serratia 
with the Human epithelial Cells Doctthesis science 
pharmaceutical. Universitélibre de Bruxelles; 1993. p. 158. 
16. Berche P, Gaillard JL, Simonet M. In nosocomial infections 
caused by bacteriaand their prevention in bacteriology edited 
by: Flammarion Med Sci; 1988. p. 64-71. 
17. Wolfe EF, Klepser ME, Pfaller MA. Antifungal dynamics of 
amphotericin Band fluconazole in combination against Candida 
albicans, effect of exposure time. Pharmacotherapy 1997; 
17:189-9. 
18. Rabe T, van Staden J. Antibacterial activity of South African 
plants used for medicinal purposes. J Ethnopharmacol 1997b; 
56:81-7. 
19. White RL, Bugess DS, Manduru M, Bosso JA. Comparison of 
three different in vitro methods of detecting synergy: Time-kill, 
chercher board, and Etest. Antimicrob Agents Chemother 
1996;40:1914-8. 
20. National Committee for Clinical Laboratory Standards: 
Methods for Determining Bactericidal Activity of Antimicrobial 
Agent. Wayne, Pa: National Committee for Clinacal Laboratory 
Standards; 1992b. 
21. Karou D, Savadogo A, Canini A, Yameogo S, Montesano C, 
Simpore J, et al. Antibacterial activity of alkaloids from Sida 
acuta. Afr J Biotechnol 2006;5:195-200. 
22. Miller LC, Tainter ML. Estimation of the LD50 and its error by 
means of logarithmic probit graph paper. Proceedings Soc Exp 
Biol Med 1944;57:261-4.  
23. Alperman H. Bericht uber pharmakologische untersuchungen 
mit fenbendazol. Abteilung Fur Pharmakologie 1972;863:1-9.  
24. Awouters F, Niemegeers CJ, Kuyps J, Janssen PA. Loperamide 
antagonism of castoroil-induced diarrhea in rats: a quantitative 
study. Arch Int Pharmacodyn Ther 1975;217:29-37. 
25. Robert A, Nezamis JE, Lancaster C, Hanchar AJ, Klepper MS. 
Enteropoolingassay: a test for diarrhea produced by 
prostaglandins. Prostaglandins 1976;11:809–28. 
26. Malathi S, Sekar T, Sujatha S. Antimicrobial and free radical 
scavenging activity of leaf and stem extract of Limonia alata 
wight and ARN. Asian J Pharm Clin Res 2018;11:360-5. 
27. Ravikumar S, Nazar S, Nuralshiefa A, Abideen S. Antibacterial 
activity of traditional therapeutic coastal medicinal plants 
against some pathogens. J Environ Biol 2005;26:383-6. 
28. Parekh J, Sumitra C. In vitro antimicrobial of extracts of 
Launaea procumbens Roxb. (Labiateae), Vitisvinifera L. 
(Vitaceae) and cyperusrotundus L. (Cyperaceae). Afr J Biomed 
Res 2006;9:89-93. 
29. Machado TD, Leal ICR, Amaral ACF, dos Santos KRN, da Siva 
MG, Kuster RM. Antimicrobial ellagitannin of Punicagranutum 
fruits. J Braz Chem Soc 2002;13:606-10. 
30. Shrivastava SM, Kumar S, Chaudhary M. Time-kill curve studies 
of against Escherichia coli, Staphylococcus aureus, Klebsiella 
pneumonia and Proteus vulgaris. Res J Med Plant 2009;3:116-22. 
Kiessoun et al. 
Int J Pharm Pharm Sci, Vol 10, Issue 10, 62-68 
 
68 
31. Jazani NH, Zartoshti M, Shahabi S, Yekta Z, Nateghi S. 
Evaluation of thesynergetic effect of water-soluble extracts of 
green tea (Camelliasinensis) on the activity of ciprofloxacin in 
urinary isolated E. coli. J Biol Sci 2007;7:1500-3. 
32. Abeer M, Haj A, Sanaa OY. Anti-microbial activity of acacia 
nilotica extracts against some bacteria isolated from clinical 
specimens. Res J Med Plant 2007;1:25-8. 
33. Cowan MM. Plants products as antimicrobial agents. Clin 
Microbiol Rev 1999;12:564-82. 
34. Machado TD, ICR Leal, ACFA Maral, KRN dos Santos, MG da Siva 
et al. Antimicrobial ellagitannin of Punicagranutum fruits. J 
Brazilian Chem Soc 2002;13:606-10. 
35. Scalbert A. Antimicrobial properties of tannins. Phytochemistry 
1991;30:3875-83. 
36. Gao Y, Belkum MJV, Stiles M. The outer membrane of Gram-
negative bacteria inhibits the antibacterial activity of Brochocin 
C. Appl Environ Microbiol 1999;65:4329-33. 
37. Patel D Jayshree, Kumar Vipin. Annonasquamosa L. 
phytochemical analysis and antimicrobial screening. J Pharm 
Res 2008;1:34-8.  
38. Gupta MB, Nath R, Srivastava N. Anti-inflammatory and 
antipyretic activities of beta-sitosterol. Int J Immunopharmacol 
1996;18:693-7.  
39. Bouic PJ, Lamprecht JH. Plant sterols and sterolins: a review of 
their immune-modulating properties. Altern Med Rev 
1999;4:170-7.  
40. Gaginella T, Phillips SF. Ricinoleic acid: a current view of 
ancient oil. Dig Dis Sci 1975;23:1171-7. 
 
